We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Compounds Target Key Enzyme Halting SARS-CoV-2 Replication

News   Jul 07, 2020 | Original story from University of South Florida Health (USF Health)

 
Compounds Target Key Enzyme Halting SARS-CoV-2 Replication

Three configurations of active sites where inhibitor GC-376 binds with the COVID-19 virus's main protease (drug target Mpro), as depicted by 3D computer modeling. Credit: Image generated by Yu Chen, University of South Florida Health, using X-ray crystallography

 
 
Advertisement
 

RELATED ARTICLES

Mouthwash Could Reduce SARS-CoV-2 Short-Term Viral Load, Cell Culture Study Suggests

News

Results from cell culture experiments show that commercially available preparations have an effect on Sars-Cov-2 viruses.

READ MORE

Bacterial Communities Cope Better When Multiple Species Are Present

News

Perturbations in the environment are common, and bacterial communities consisting of several species seem to find their way around the crisis. Species immigration is beneficial for community recovery, an international study shows.

READ MORE

New Process Accelerates Synthesis of Antiviral and Anticancer Drugs

News

Using a new process, scientists can create new nucleoside analogues months earlier than with the previous method, paving the way for quicker drug discoveries.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE